Sunil Abhyankar, MD
Hematology & Oncology · Westwood, KSNPI 1972575488
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (43.8%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. Incyte Corporation accounts for 60.1% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2019 at $44,184 and has fallen 72.4% since, to $12,177 in 2025. Among hematology & oncology clinicians in KS with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 68 payments — averaging $1148.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Incyte Corporation$47K
- Mallinckrodt Enterprises LLC$17K
- CSL Behring$9K
- Gilead$5K
- Genmab U.S., Inc.$124
- Carl Zeiss Meditec, Inc.$104
- plus $125 from 4 others
Across 442 payments — averaging $11,215 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Jazz Pharmaceuticals Inc.$2.5M
- CSL Behring$1.7M
- Incyte Corporation$346K
- Genentech, Inc.$158K
- National Marrow Donor Program$152K
- Deciphera Pharmaceuticals Inc.$110K
- plus $32K from 4 others
What the payments were for
- Consulting fees$27,13435%
- Speaking & faculty fees$34,24844%
- Travel & lodging$15,21019%
- Food & beverage$1,5162%
- Education$140%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Incyte Corporation | 42 | $46,923 |
| Mallinckrodt Enterprises LLC | 5 | $16,843 |
| CSL Behring | 12 | $8,859 |
| Gilead | 3 | $5,143 |
| Genmab U.S., Inc. | 1 | $124 |
| Carl Zeiss Meditec, Inc. | 1 | $104 |
| Sanofi-aventis U.S. LLC | 1 | $42 |
| Genentech USA, Inc. | 1 | $36 |
| AbbVie | 1 | $34 |
| Acrotech Biopharma Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- JAKAFI$36,552
- CELLEX/XTS PHOTOPHERESIS SYSTEM$16,843
- NIKTIMVO$7,293
- Tecartus$5,000
- VisuMax$104
How this compares
$78,121 in reported general payments places this provider in the 90th percentile of 97 hematology & oncology providers in Kansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Posaconazole | 20 | $21,083 |
| Atovaquone | 15 | $6,964 |
| ArexvyRsvpref3 Antigen/As01e/Pf | 11 | $2,862 |
| Acyclovir | 116 | $2,505 |
| ShingrixVaricella-Zoster Ge/As01b/Pf | 12 | $2,141 |
| Menveo A-C-Y-W-135-DipMening Vac A,c,y,w-135 Dip/Pf | 11 | $1,878 |
| Ursodiol | 15 | $1,656 |
| PentacelDipht,pert(A),tet-Polio/Hib/Pf | 16 | $1,606 |
| Fluconazole | 18 | $1,038 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 104 | $646 |
| Penicillin V Potassium | 35 | $631 |
| Hydrocortisone | 19 | $619 |
| Dapsone | 12 | $523 |
| Gabapentin | 29 | $486 |
| Potassium Chloride | 19 | $452 |
Paid to pharmacies, not to this prescriber.
Other hematology & oncology in Westwood
- Priyanka SharmaWestwood$135K
- Gary DoolittleWestwood$102K
- Leyla ShuneWestwood$56K
- Anthony SungWestwood$49K
- Anup Kumar Kasi Loknath KumarWestwood$31K
- Prakash NeupaneWestwood$26K
- Muhammad Umair MushtaqWestwood$21K
- Jesus Gonzalez LugoWestwood$4K
- Qamar KhanWestwood$1K
- Tahani AtiehWestwood$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.